Dennis J. Hartigan-O'Connor, Ph.D.

2003 University of Michigan, Ann Arbor, Ann Arbor, MI 
muscle gene therapy, DMD
"Dennis Hartigan-O'Connor"


Sign in to add mentor
Jeffrey Chamberlain grad student 2003 University of Michigan
 (Adenoviral vectors for treatment of Duchenne muscular dystrophy.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Santos Rocha C, Hirao LA, Weber MG, et al. (2018) Subclinical cytomegalovirus infection associates with altered host immunity, gut microbiota and vaccine responses. Journal of Virology
Méndez-Lagares G, Lu D, Merriam D, et al. (2017) IL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8(+) T Cell Responses in Acute Simian Immunodeficiency Virus Infection. Aids Research and Human Retroviruses. 33: S81-S92
Merriam DP, Chen C, Mendez-Lagares G, et al. (2017) Depletion of gut-resident CCR5+ cells for HIV cure strategies. Aids Research and Human Retroviruses
Hartigan-O'Connor DJ, Jacobson MA, Tan QX, et al. (2011) Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 409-17
Mi J, Barker S, Meuse L, et al. (2004) 460. Immunogenicity of E2b-Deleted Adenoviral Vectors Compared with First Generation Vectors Molecular Therapy. 9
Mi J, Leuse L, Scott J, et al. (2004) 240. Immunogenicity of Dystrophins Delivered to Mice by Gutted Adenoviral Vectors Molecular Therapy. 9
DelloRusso C, Scott JM, Hartigan-O'Connor D, et al. (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proceedings of the National Academy of Sciences of the United States of America. 99: 12979-84
Barjot C, Hartigan-O'Connor D, Salvatori G, et al. (2002) Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses. The Journal of Gene Medicine. 4: 480-9
Hartigan-O'Connor D, Chamberlain JS. (2002) Progress toward gene therapy of Duchenne muscular dystrophy. Seminars in Neurology. 19: 323-32
Hartigan-O'Connor D, Barjot C, Salvatori G, et al. (2002) Generation and growth of gutted adenoviral vectors. Methods in Enzymology. 346: 224-46
See more...